SEC-sourced researchBeta

TELA

TELA Bio, Inc.

US markets

Data passport

CIK: 0001561921
Exchange: Nasdaq
Business activity: — · SIC 3841
Financial inputs: 6/6
Filing date: Oct 5, 2026
SEC registry record: Operating company

Last updated: Oct 6, 2026, 6:01 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

TELA · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2023	58,453,000.0000	Mar 25, 2026
December 2024	69,300,000.0000	Mar 25, 2026
December 2025	80,275,000.0000	Mar 25, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	80,275,000.0000	-38,831,000.0000	-28,219,000.0000	81,418,000.0000	75,105,000.0000	Mar 25, 2026
December 2024	69,300,000.0000	-37,841,000.0000	-41,595,000.0000	86,570,000.0000	58,112,000.0000	Mar 25, 2026
December 2023	58,453,000.0000	-46,664,000.0000	-40,857,000.0000	—	—	Mar 25, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenueFromContractWithCustomerExcludingAssessedTax	$80.28M	December 2025	Mar 25, 2026	10-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax	$69.3M	December 2024	Mar 25, 2026	10-K
Net incomeNetIncomeLoss	-$38.83M	December 2025	Mar 25, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$28.22M	December 2025	Mar 25, 2026	10-K
Total assetsAssets	$81.42M	December 2025	Mar 25, 2026	10-K
Total liabilitiesLiabilities	$75.11M	December 2025	Mar 25, 2026	10-K

New filings

Explore methodology ↗